Abstract

Design and development of effective anti-virals in combating CoVid-19 is a great challenge worldwide. Known drugs such as chloroquine, lopinavir, favipiravir and remdesivir are used in the management of CoVid - 19. It is known that Ivermectin and remdesivir both are effective against filoviruses, paramyxo viruses. Available data also shows that ivermectin and remedesivir repress the replication of SARS-CoV-2. Thus, we document the potential use of ivermectin and remdesivir in the management of CoVid -19.

Highlights

  • Design and development of effective anti-virals in combating CoVid-19 is a great challenge worldwide

  • It is known that Ivermectin and remdesivir both are effective against filoviruses, paramyxo viruses

  • Available data shows that ivermectin and remedesivir repress the replication of Severe Acute Respiratory Infection (SARS)-CoV-2

Read more

Summary

Introduction

Design and development of effective anti-virals in combating CoVid-19 is a great challenge worldwide. The authors are responsible for the content of this article. The authors declare that they are not withholding any information that is misleading to the publisher in regard to this article.

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.